Ocular Therapeutix (OCUL) Other Operating Expenses (2013 - 2026)
Ocular Therapeutix (OCUL) posted quarterly Other Operating Expenses of $19.3 million for Q2 2026, up 66406.9% year-over-year from N/an in Q2 2025, and up 7.71% on a QoQ basis from $17.9 million in Q1 2026.
Ocular Therapeutix (OCUL) Other Operating Expenses (2013 - 2026) Analysis & Trends
Ocular Therapeutix has reported Other Operating Expenses for 14 years, with the latest figure at $19.3 million in Q2 2026.
- Other Operating Expenses for Q2 2026 came in at $19.3 million, up 66406.9% year-over-year; the trailing twelve-month figure through Jun 2026 was $51.7 million (up 30.52% YoY), and the FY2025 annual result was $60.5 million, up 28.13% from the prior year.
- Other Operating Expenses grew to $19.3 million in Q2 2026, from $17.9 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $19.3 million in Q2 2026 and troughed at $29000.0 in Q2 2025.
- A 5-year average of $12.0 million and a median of $11.5 million in 2022 frame the typical range for Other Operating Expenses.
- The widest annual swing landed in 2025, when Other Operating Expenses tumbled 99.75%; it then surged 66406.9% in 2026.
- A 5-year view of Other Operating Expenses shows it stood at $11.5 million in 2022, then slipped by 7.91% to $10.6 million in 2023, then gained by 13.54% to $12.1 million in 2024, then climbed by 20.56% to $14.6 million in 2025, then jumped by 32.55% to $19.3 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $19.3 million in Q2 2026, $17.9 million in Q1 2026, and $14.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ocular Therapeutix | 2.20 Bn | 2.20 Bn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.29 Mn |
| Mar 31, 2026 | 17.91 Mn |
| Dec 31, 2025 | -90.78 Mn |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 44.12 Mn |
| Dec 31, 2024 | -43.83 Mn |
| Sep 30, 2024 | 12.13 Mn |
| Jun 30, 2024 | 11.50 Mn |
| Mar 31, 2024 | 22.06 Mn |
| Dec 31, 2023 | 17.58 Mn |
| Sep 30, 2023 | 10.69 Mn |
| Jun 30, 2023 | 12.46 Mn |
| Mar 31, 2023 | 12.05 Mn |
| Dec 31, 2022 | 25.08 Mn |
| Sep 30, 2022 | 14.79 Mn |
| Jun 30, 2022 | 11.30 Mn |
| Mar 31, 2022 | 14.40 Mn |
| Dec 31, 2021 | 13.69 Mn |
| Sep 30, 2021 | 10.89 Mn |
| Jun 30, 2021 | 9.49 Mn |